4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014328
Edwards Larry Todd sold 3,687 shares at an average $25.18 ($92,846)
- Edwards Larry Todd acquired 30,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-27 | Grant or award : show line 1 in the form 10b5-1 | +30,000 | 178,865 | D | ||
| 2026-03-02 | Sale : show line 2 in the form 10b5-1 | −3,584 | $25.16 | $90,177 | 175,281 | D |
| 2026-03-02 | Sale : show line 3 in the form 10b5-1 | −103 | $25.91 | $2,669 | 175,178 | D |
| Open-market sales · 3,687 sh · avg $25.18 · $92,846 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-27 | Grant or award : show line 4 in the form 10b5-1 Stock Option (right to buy) | +77,000 | 77,000 | D |
Loading xslF345X05/wk-form4_1772588580.xml…